A.M.E. Claessen

1.9k total citations
38 papers, 1.4k citations indexed

About

A.M.E. Claessen is a scholar working on Immunology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A.M.E. Claessen has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A.M.E. Claessen's work include Immunotherapy and Immune Responses (10 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers) and Sarcoidosis and Beryllium Toxicity Research (9 papers). A.M.E. Claessen is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers) and Sarcoidosis and Beryllium Toxicity Research (9 papers). A.M.E. Claessen collaborates with scholars based in Netherlands, Belgium and Guinea-Bissau. A.M.E. Claessen's co-authors include Jan C. Grutters, Rik J. Scheper, Adriane D.M. Vorselaars, Herbert M. Pinedo, Coline H.M. van Moorsel, Chris J.L.M. Meijer, Jan B. Vermorken, Sybren L. Meijer, Elisabeth Bloemena and Heleen van Velzen‐Blad and has published in prestigious journals such as The Lancet, The Journal of Immunology and Journal of Controlled Release.

In The Last Decade

A.M.E. Claessen

38 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.M.E. Claessen Netherlands 20 626 442 342 320 317 38 1.4k
Anne Richter Germany 21 875 1.4× 314 0.7× 470 1.4× 104 0.3× 121 0.4× 59 1.8k
Abdelali Filali‐Mouhim Canada 20 522 0.8× 286 0.6× 432 1.3× 130 0.4× 133 0.4× 35 1.4k
Romina Gamberale Argentina 19 782 1.2× 156 0.4× 473 1.4× 136 0.4× 113 0.4× 44 1.5k
Amha Atakilit United States 21 448 0.7× 329 0.7× 691 2.0× 113 0.4× 137 0.4× 31 1.6k
Fumiya Hirayama Japan 24 794 1.3× 279 0.6× 341 1.0× 128 0.4× 94 0.3× 103 1.9k
Philipp Müller Switzerland 18 706 1.1× 981 2.2× 371 1.1× 81 0.3× 230 0.7× 33 1.9k
Haruo Nagumo Japan 18 1.7k 2.7× 211 0.5× 395 1.2× 264 0.8× 120 0.4× 26 2.2k
Zoya Kurago United States 20 551 0.9× 273 0.6× 354 1.0× 138 0.4× 81 0.3× 40 1.7k
Janet North United Kingdom 23 908 1.5× 249 0.6× 305 0.9× 873 2.7× 283 0.9× 33 1.9k
Anna Haemel United States 14 347 0.6× 224 0.5× 259 0.8× 128 0.4× 102 0.3× 40 1.0k

Countries citing papers authored by A.M.E. Claessen

Since Specialization
Citations

This map shows the geographic impact of A.M.E. Claessen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M.E. Claessen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M.E. Claessen more than expected).

Fields of papers citing papers by A.M.E. Claessen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M.E. Claessen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M.E. Claessen. The network helps show where A.M.E. Claessen may publish in the future.

Co-authorship network of co-authors of A.M.E. Claessen

This figure shows the co-authorship network connecting the top 25 collaborators of A.M.E. Claessen. A scholar is included among the top collaborators of A.M.E. Claessen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M.E. Claessen. A.M.E. Claessen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barwari, Kurdo, A.M.E. Claessen, Vincent van der Noort, et al.. (2023). Histopathological Concordance between Prostate Biopsies and Radical Prostatectomy Specimens – Implications of Transrectal and Transperineal Biopsy Approaches. European Urology Open Science. 57. S60–S61. 1 indexed citations
2.
Barwari, Kurdo, A.M.E. Claessen, Vincent van der Noort, et al.. (2023). Histopathological concordance between prostate biopsies and radical prostatectomy specimens—implications of transrectal and transperineal biopsy approaches. Prostate Cancer and Prostatic Diseases. 27(2). 312–317. 4 indexed citations
3.
Meek, Bob, et al.. (2018). Rheumatoid factor isotype and Ro epitope distribution in primary Sjögren syndrome and rheumatoid arthritis with keratoconjunctivitis sicca. Rheumatology International. 38(8). 1487–1493. 12 indexed citations
4.
Vorselaars, Adriane D.M., Heleen A. Crommelin, Vera H.M. Deneer, et al.. (2015). Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis. European Respiratory Journal. 46(1). 175–185. 106 indexed citations
5.
Vorselaars, Adriane D.M., Coline H.M. van Moorsel, Pieter Zanen, et al.. (2014). ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy. Respiratory Medicine. 109(2). 279–285. 82 indexed citations
6.
Hijdra, Daniëlle, Adriane D.M. Vorselaars, Jan C. Grutters, A.M.E. Claessen, & Ger T. Rijkers. (2013). Phenotypic Characterization of Human Intermediate Monocytes. Frontiers in Immunology. 4. 339–339. 51 indexed citations
7.
Hijdra, Daniëlle, Adriane D.M. Vorselaars, Jan C. Grutters, A.M.E. Claessen, & Ger T. Rijkers. (2012). Differential expression of TNFR1 (CD120a) and TNFR2 (CD120b) on subpopulations of human monocytes. Journal of Inflammation. 9(1). 38–38. 39 indexed citations
8.
Heron, Michiel, Jan C. Grutters, Coline H.M. van Moorsel, et al.. (2009). Variation in IL7R predisposes to sarcoid inflammation. Genes and Immunity. 10(7). 647–653. 32 indexed citations
9.
Heron, Michiel, Jan C. Grutters, Heleen van Velzen‐Blad, et al.. (2008). Increased Expression of CD16, CD69, and Very Late Antigen-1 on Blood Monocytes in Active Sarcoidosis. CHEST Journal. 134(5). 1001–1008. 37 indexed citations
10.
Velden, Ankie M.T. van der, A.M.E. Claessen, Heleen van Velzen‐Blad, Douwe H. Biesma, & Ger T. Rijkers. (2007). Development of T cell-mediated immunity after autologous stem cell transplantation: prolonged impairment of antigen-stimulated production of γ-interferon. Bone Marrow Transplantation. 40(3). 261–266. 11 indexed citations
11.
Velden, Ankie M.T. van der, A.M.E. Claessen, Heleen van Velzen‐Blad, et al.. (2007). Vaccination responses and lymphocyte subsets after autologous stem cell transplantation. Vaccine. 25(51). 8512–8517. 20 indexed citations
12.
Velden, Ankie M.T. van der, Heleen van Velzen‐Blad, A.M.E. Claessen, et al.. (2007). The effect of ranitidine on antibody responses to polysaccharide vaccines in patients with B‐cell chronic lymphocytic leukaemia. European Journal Of Haematology. 79(1). 47–52. 18 indexed citations
13.
Baars, Arnold, A.M.E. Claessen, John Wagstaff, et al.. (2002). A phase II study of active specific immunotherapy and5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma. British Journal of Cancer. 86(8). 1230–1234. 21 indexed citations
14.
Eertwegh, Alfons J.M. van den, A.M.E. Claessen, Harm van Tinteren, et al.. (2000). Actieve specifieke immunotherapie als adjuvante behandeling van patiënten met coloncarcinoom in stadium II of III: prospectief gerandomiseerd onderzoek. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 144(6). 274–279. 1 indexed citations
15.
Baars, Arnold, A.M.E. Claessen, H.E. Gall, et al.. (2000). Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: Experience in 81 patients. Annals of Oncology. 11(8). 965–970. 49 indexed citations
16.
Vermorken, Jan B., A.M.E. Claessen, Harm van Tinteren, et al.. (1999). Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. The Lancet. 353(9150). 345–350. 379 indexed citations
17.
Broxterman, HJ, G.J. Schuurhuis, J. Lankelma, et al.. (1997). Highly sensitive and specific detection of P-glycoprotein function for haematological and solid tumour cells using a novel nucleic acid stain. British Journal of Cancer. 76(8). 1029–1034. 31 indexed citations
18.
Brevé, John J. P., et al.. (1995). Oral Tolerance is Determined at the Level of Draining Lymph Nodes. Immunobiology. 194(4-5). 403–414. 12 indexed citations
19.
Claessen, A.M.E., et al.. (1991). Tumor regression and induction of anti‐tumor immunity by local chemotherapy of guinea‐pigs bearing a line‐10 hepatocarcinoma. International Journal of Cancer. 47(4). 626–632. 9 indexed citations
20.
Steerenberg, Peter A., Wim H. de Jong, Anneke Elgersma, et al.. (1990). Tumor infiltrating leukocytes (tils) during progressive tumor growth and BCG-mediated tumor regression. Virchows Archiv B Cell Pathology Including Molecular Pathology. 59(1). 185–194. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026